We invite you to view the DERM2022 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.
Poster 43
Effectiveness, safety, and quality of life from a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe psoriasis
Authors: Neal Bhatia, Jayme Heim, Brad Schenkel, Stephen J Rozzo, J Gabriel Vasquez